A Study of Volociximab in Metastatic Melanoma

Mise à jour : Il y a 4 ans
Référence : NCT00369395

Femme et Homme

Extrait

This is a Phase 2, multicenter, research study determining the effects of an investigational drug called volociximab in metastatic melanoma. The purpose of the study is to compare the clinical benefit and safety of volociximab. Pharmacokinetics and mechanism of action will also be evaluated.


Critère d'inclusion

  • Stage IV Melanoma

Liens